Founded in 2002 by experienced industry
executives, Proreo Pharma AG is a privately owned
Swiss based specialty pharmaceutical company.
With emphasis on the therapeutic areas of central
nervous system, gastroenterology, rheumatology, and surgery, Proreo Pharma focuses on
the acquisition, development, and commercialization
of innovative specialist medicines.
In Switzerland and France, the company uses its own
commercial infrastructure to market its products.
Further presence and reach is achieved via a network
of distribution partners.
Proreo Pharma also has a sister company in
Switzerland, Proreo Pharma Innovation AG, which is fully
dedicated to the company's research and development
activities. |
|
News
05.02.2007
Speciality European Pharma Ltd acquires Proreo
Pharma International AG. Proreo Pharma AG not part of
this transaction.
Press
Release
|
